The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase I clinical trial of cancer vaccine with five novel epitope peptides for patients with metastatic colorectal cancer (mCRC).
S. Hazama
No relevant relationships to disclose
M. Oka
No relevant relationships to disclose
K. Yoshida
No relevant relationships to disclose
T. Tsunoda
No relevant relationships to disclose
S. Yoshino
No relevant relationships to disclose
Y. Hinoda
No relevant relationships to disclose
Y. Nakamura
No relevant relationships to disclose